Reovirus--a recent finding that this virus can kill prostate cancer cells. These are Canadian researchers and they are only entering phase I trial. This could have major implications for not only companies like DNDN but other oncology companies as well.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.